About: Raising the bar for market authorisation of new drugs

Documentation

scienceplus.abes.fr version Bêta

scienceplus.abes.fr | explorer

À propos de : Raising the bar for market authorisation of new drugs Goto Sponge NotDistinct Permalink

Attributs	Valeurs
type	work Article
Is Part Of	http://hub.abes.fr/bmj/periodical/bmj/2012/volume_345/issue_2012/w
Subject	analysis
Title	Raising the bar for market authorisation of new drugs
has manifestation of work	http://hub.abes.fr/bmj/periodical/bmj/2012/volume_345/issue_2012/B36F2EC4374D586AE053120B220A42AF/m/print http://hub.abes.fr/bmj/periodical/bmj/2012/volume_345/issue_2012/B36F2EC4374D586AE053120B220A42AF/m/web
related by	http://hub.abes.fr/bmj/periodical/bmj/2012/volume_345/issue_2012/B36F2EC4374D586AE053120B220A42AF/authorship/5 http://hub.abes.fr/bmj/periodical/bmj/2012/volume_345/issue_2012/B36F2EC4374D586AE053120B220A42AF/authorship/3 http://hub.abes.fr/bmj/periodical/bmj/2012/volume_345/issue_2012/B36F2EC4374D586AE053120B220A42AF/authorship/4 http://hub.abes.fr/bmj/periodical/bmj/2012/volume_345/issue_2012/B36F2EC4374D586AE053120B220A42AF/authorship/2 http://hub.abes.fr/bmj/periodical/bmj/2012/volume_345/issue_2012/B36F2EC4374D586AE053120B220A42AF/authorship/1
Abstract	Huseyin Naci and colleagues find that raising evidence standards for market entry of new drugs could have numerous benefits, including providing incentives for development in therapeutic areas with few treatment options
article type	other
publisher identifier	nach005670
is part of this journal	British Medical Journal

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata